Treatment of Selective Serotonin Reuptake Inhibitor-Resistant Depression in Adolescents: Predictors and Moderators of Treatment Response
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objective To advance knowledge regarding strategies for treating selective serotonin reuptake inhibitor (SSRI)–resistant depression in adolescents, we conducted a randomized controlled trial evaluating alternative treatment strategies. In primary analyses, cognitive-behavioral therapy (CBT) combined with medication change was associated with higher rates of positive response to short-term (12-week) treatment than medication alone. This study examines predictors and moderators of treatment response, with the goal of informing efforts to match youths to optimal treatment strategies. Method Youths who had not improved during an adequate SSRI trial (N = 334) were randomized to an alternative SSRI, an alternative SSRI plus CBT, venlafaxine, or venlafaxine plus CBT. Analyses examined predictors and moderators of treatment response. Results Less severe depression, less family conflict, and absence of nonsuicidal self-injurious behavior predicted better treatment response status. Significant moderators of response to CBT + medication (combined) treatment were number of comorbid disorders and abuse history; hopelessness was marginally significant. The CBT/combined treatment superiority over medication alone was more evident among youths who had more comorbid disorders (particularly attention-deficit/hyperactivity disorder and anxiety disorders), no abuse history, and lower hopelessness. Further analyses revealed a stronger effect of combined CBT + medication treatment among youths who were older and white and had no nonsuicidal self-injurious behavior and longer prestudy pharmacotherapy. Conclusions Combined treatment with CBT and antidepressant medication may be more advantageous for adolescents whose depression is comorbid with other disorders. Given the additional costs of adding CBT to medication, consideration of moderators in clinical decision making can contribute to a more personalized and effective approach to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
The measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056
Self-citationCognitive Therapy for the Prevention of Suicide Attempts: A Randomized Controlled Trial
Brown, G. K., Ten Have, T., Henriques, G. R., Xie, S. X., Hollander, J. E., & Beck, A. T. (2005) · JAMA · doi:10.1001/jama.294.5.563 · Cited by 1,045
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.997 · Cited by 580
Reynolds, W. M., & Mazza, J. J. (1999) · School Psychology Review · doi:10.1080/02796015.1999.12085945 · Cited by 300
Research works printed but not linked: 20
- Brent, 2008, JAMA, 299, 901, 10.1001/jama.299.8.901 · DOI · Paper page
- Curry, 2006, J Am Acad Child Adolesc Psychiatry, 45, 1427, 10.1097/01.chi.0000240838.78984.e2 · DOI · Paper page
- Emslie, 1998, Depression Anxiety, 7, 32, 10.1002/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0.CO;2-7 · doi:10.1002/(sici)1520-6394(1998)7:1<32::aid-da4>3.0.co;2-7
- Birmaher, 2000, Arch Gen Psychiatry, 57, 29, 10.1001/archpsyc.57.1.29 · DOI · Paper page
- Brent, 1998, J Am Acad Child Adolesc Psychiatry, 37, 906, 10.1097/00004583-199809000-00010 · DOI · Paper page
- Clarke, 1992, Behav Ther, 23, 341, 10.1016/S0005-7894(05)80162-5 · DOI · Paper page
- Rohde, 2006, J Consult Clin Psychol, 74, 80, 10.1037/0022-006X.74.1.80 · DOI · Paper page
- Barbe, 2004, J Clin Psychiatry, 65, 77, 10.4088/JCP.v65n0113 · DOI
- Barbe, 2004, Suicide Life Threat Behav, 34, 44, 10.1521/suli.34.1.44.27768 · DOI
- Poznanski, 1984, Psychopharmacol Bull, 21, 979
- Begg, 1980, Biometrics, 36, 81, 10.2307/2530497 · DOI · Paper page
- Kaufman, 1997, J Am Acad Child Adolesc Psychiatry, 36, 980, 10.1097/00004583-199707000-00021 · DOI · Paper page
- Kirisci, 1995, Addict Behav, 20, 149, 10.1016/0306-4603(94)00058-1 · DOI
- Ascher, 1996, J Emot Behav Disord, 4, 12, 10.1177/106342669600400102 · DOI · Paper page
- Nock, 2008, Behav Ther, 39, 107, 10.1016/j.beth.2007.05.005 · DOI · Paper page
- Asarnow, 2005, JAMA, 293, 311, 10.1001/jama.293.3.311 · DOI · Paper page
- Nemeroff, 2003, Proc Natl Acad Sci U S A, 100, 14293, 10.1073/pnas.2336126100 · DOI · Paper page
- Weisz, 1997, J Consult Clin Psychol, 65, 703, 10.1037/0022-006X.65.4.703 · DOI · Paper page
- Tompson, 2007, Clin Child Psychol Psychiatry, 12, 403, 10.1177/1359104507078474 · DOI
- Miranda, 2005, Annu Rev Clin Psychol, 1, 113, 10.1146/annurev.clinpsy.1.102803.143822 · DOI · Paper page
Cited by
Comorbidity of anxiety and depression in children and adolescents: 20 years after
Cummings, C. M., Caporino, N. E., & Kendall, P. C. (2014) · Psychological Bulletin · doi:10.1037/a0034733 · Cited by 1,028
“…was largely no impact of comorbid anxiety on psychoeducational therapy for mood disorders (Cummings & Fristad, 2012), a school-based universal prevention program (Pössel, Seeman, & Hautzinger, 2008), or combined medication and psychotherapy for treatment resistant depression (Asarnow et al., 2009).”
Asarnow, J. R., Porta, G., Spirito, A., Emslie, G., Clarke, G., Wagner, K. D., Vitiello, B., Keller, M., Birmaher, B., McCracken, J., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.04.003 · Cited by 632
Evidence Base Update of Psychosocial Treatments for Child and Adolescent Depression
Weersing, V. R., Jeffreys, M., Do, M.-C. T., Schwartz, K. T. G., & Bolano, C. (2017) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2016.1220310 · Cited by 505
McMakin, D. L., Olino, T. M., Porta, G., Dietz, L. J., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Ryan, N. D., Birmaher, B., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.011 · Cited by 448
Exercise Benefits Brain Function: The Monoamine Connection
Lin, T.-W., & Kuo, Y.-M. (2013) · Brain Sciences · doi:10.3390/brainsci3010039 · Cited by 392
“5-HT is regarded as the keystone in the psycho-emotional symptoms of depression and anxiety [56,57]; antagonists of 5-HT transporter have been widely used to ameliorate neuropsychiatric symptoms [58].”
Background
Metadata
- Authors
- ASARNOW, J. R., EMSLIE, G., CLARKE, G., WAGNER, K. D., SPIRITO, A., VITIELLO, B., IYENGAR, S., SHAMSEDDEEN, W., RITZ, L., BIRMAHER, B., RYAN, N., KENNARD, B., MAYES, T., DEBAR, L., MCCRACKEN, J., STROBER, M., SUDDATH, R., LEONARD, H., PORTA, G., KELLER, M., & BRENT, D.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 48
- Issue
- 3
- Pages
- 330-339
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2087545180
- Cited by
- 183
- References
- 13
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Selective Serotonin Reuptake Inhibitor-Resistant Depression in Adolescents: Predictors and Moderators of Treatment Response. https://app.cochat.ai/papers/10.1097/chi.0b013e3181977476
- The paper
- ASARNOW, J. R., EMSLIE, G., CLARKE, G., WAGNER, K. D., SPIRITO, A., VITIELLO, B., IYENGAR, S., SHAMSEDDEEN, W., RITZ, L., BIRMAHER, B., RYAN, N., KENNARD, B., MAYES, T., DEBAR, L., MCCRACKEN, J., STROBER, M., SUDDATH, R., LEONARD, H., PORTA, G., . . . BRENT, D. (2009). Treatment of Selective Serotonin Reuptake Inhibitor-Resistant Depression in Adolescents: Predictors and Moderators of Treatment Response. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/chi.0b013e3181977476
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.